Quan Vega, M. L., Chihuri, S. T., Lackraj, D., Murali, K. P., Li, G., & Hua, M. (2023). Place of Death From Cancer in US States With vs Without Palliative Care Laws. JAMA Network Open, 6(6), e2317247. https://doi.org/10.1001/jamanetworkopen.2023.17247

Obradovic, A., Ager, C., Turunen, M., Nirschl, T., Khosravi-Maharlooei, M., Iuga, A., Jackson, C. M., Yegnasubramanian, S., Tomassoni, L., Fernandez, E. C., McCann, P., Rogava, M., DeMarzo, A. M., Kochel, C. M., Allaf, M., Bivalacqua, T., Lim, M., Realubit, R., Karan, C., … Califano, A. (2023). Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell, 41(5), 933-949.e11. https://doi.org/10.1016/j.ccell.2023.04.003

Du, M., Griecci, C. F., Cudhea, F., Eom, H., Wong, J. B., Wilde, P., Kim, D. D., Michaud, D. S., Wang, Y. C., Mozaffarian, D., & Zhang, F. F. (2023). What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA. BMJ Open, 13(4), e063614. https://doi.org/10.1136/bmjopen-2022-063614

Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T., Demir, I. E., Deneen, B., Gutmann, D. H., Hervey-Jumper, S., Kuner, T., Mabbott, D., Platten, M., Rolls, A., Sloan, E. K., Wang, T. C., Wick, W., Venkataramani, V., & Monje, M. (2023). Cancer neuroscience: State of the field, emerging directions. Cell, 186(8), 1689–1707. https://doi.org/10.1016/j.cell.2023.02.002

LaRose, M., Connolly, R. M., O’Sullivan, C. C., Velcheti, V., Vilimas, R., Gano, K., Bates, S. E., Pommier, Y., & Thomas, A. (2023). A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors. The Oncologist, 28(5), 460-e298. https://doi.org/10.1093/oncolo/oyad023

Ahmed, F., Kang, I. S., Kim, K. H., Asif, A., Rahim, C. S. A., Samantasinghar, A., Memon, F. H., & Choi, K. H. (2023). Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches. Journal of Medical Virology, 95(4). Portico. https://doi.org/10.1002/jmv.28693

van Heerden, J., Lisa Christine, I., Downing, J., Davidson, A., Hessissen, L., Schoeman, J., Ladas, E. J., Abdelhafeez, H., Georgia Odongo Arao, S., Fentie, A. M., Kamal, S., Parkes, J., Naiker, T., Ludick, A., Balagadde-Kambugu, J., & Geel, J. (2022). Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer. Pediatric Hematology and Oncology, 40(3), 224–241. https://doi.org/10.1080/08880018.2022.2117882

Chidebe, R. C. W., Leibel, L. L., Orjiakor, T. C., Shrestha, A., Agha, A. A., Altinok Dindar, D., Kisakol, B., Ipiankama, S. C., Okoye, I. J., Mason, M., Auguste, A., & Esiaka, D. K. (2023). Promoting cancer prevention through World Cancer Day in Nigeria. The Lancet Oncology, 24(4), 319–322. https://doi.org/10.1016/s1470-2045(22)00692-1

Pang, J., Xia, H., Mi, S., Zhang, W., Pendrick, D., Freeman, C., Fernandes, H., Mansukhani, M., & Hsiao, S. J. (2022). Benchmarking bioinformatics approaches for tumour mutational burden evaluation from a large cancer panel against whole-exome sequencing. Journal of Clinical Pathology, 76(4), 276–280. https://doi.org/10.1136/jcp-2022-208385

Lehrnbecher, T., Robinson, P. D., Ammann, R. A., Fisher, B., Patel, P., Phillips, R., Beauchemin, M. P., Carlesse, F., Castagnola, E., Davis, B. L., Elgarten, C. W., Groll, A. H., Haeusler, G. M., Koenig, C., Santolaya, M. E., Tissing, W. J. E., Wolf, J., Alexander, S., Hu, H., … Sung, L. (2023). Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of Clinical Oncology, 41(9), 1774–1785. https://doi.org/10.1200/jco.22.02224

Gounder, M. M., Bauer, T. M., Schwartz, G. K., Weise, A. M., LoRusso, P., Kumar, P., Tao, B., Hong, Y., Patel, P., Lu, Y., Lesegretain, A., Tirunagaru, V. G., Xu, F., Doebele, R. C., & Hong, D. S. (2023). A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of Clinical Oncology, 41(9), 1714–1724. https://doi.org/10.1200/jco.22.01285

Savage, T. M., Vincent, R. L., Rae, S. S., Huang, L. H., Ahn, A., Pu, K., Li, F., de los Santos-Alexis, K., Coker, C., Danino, T., & Arpaia, N. (2023). Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity. Science Advances, 9(10). https://doi.org/10.1126/sciadv.adc9436

Miholjcic, T. B. S., Halse, H., Bonvalet, M., Bigorgne, A., Rouanne, M., Dercle, L., Shankar, V., & Marabelle, A. (2023). Rationale for LDH-targeted cancer immunotherapy. European Journal of Cancer, 181, 166–178. https://doi.org/10.1016/j.ejca.2022.11.032

Beauchemin, M. P., Lichtenstein, M. R. L., Raghunathan, R., Doshi, S. D., Lee, S., Law, C., Accordino, M. K., Elkin, E. B., Wright, J. D., & Hershman, D. L. (2023). Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs. JCO Oncology Practice, 19(3), e326–e335. https://doi.org/10.1200/op.22.00451

Orimoloye, H. T., Qureshi, N., Lee, P., Wu, C., Saechao, C., Federman, N., Li, C., Ritz, B., Arah, O. A., & Heck, J. E. (2023). Maternal anemia and the risk of childhood cancer: A population‐based cohort study in Taiwan. Pediatric Blood & Cancer, 70(3). Portico. https://doi.org/10.1002/pbc.30188

Baker, W. L., Moore, T. E., Baron, E., Jennings, D. L., & Jaiswal, A. (2022). Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in Transplantation, 33(1), 69–77. https://doi.org/10.1177/15269248221145042

Kim, C., Wang, X.-D., Jang, S., & Yu, Y. (2023). PARP1 inhibitors induce pyroptosis via caspase 3-mediated gasdermin E cleavage. Biochemical and Biophysical Research Communications, 646, 78–85. https://doi.org/10.1016/j.bbrc.2023.01.055

Santesso, N., Beauchemin, M., Robinson, P. D., Walsh, A. M., Sugalski, A. J., Lo, T., Dang, H., Fisher, B. T., Grimes, A. C., Wrightson, A. R., Yu, L. C., Sung, L., & Dupuis, L. L. (2023). Clinical practice guideline recommendation summaries for pediatric oncology health care professionals: A qualitative study. PLOS ONE, 18(2), e0281890. https://doi.org/10.1371/journal.pone.0281890

Obradovic, A. (2023). Precision immunotherapy. Science, 379(6633), 654–655. https://doi.org/10.1126/science.adg5585

Greene, L. A., Zhou, Q., Siegelin, M. D., & Angelastro, J. M. (2023). Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. Cells, 12(4), 581. https://doi.org/10.3390/cells12040581

Li, T., Kikuchi, O., Zhou, J., Wang, Y., Pokharel, B., Bastl, K., Gokhale, P., Knott, A., Zhang, Y., Doench, J. G., Ho, Z. V., Catenacci, D. V. T., & Bass, A. J. (2023). Developing SHP2-based combination therapy for KRAS-amplified cancer. JCI Insight, 8(3). https://doi.org/10.1172/jci.insight.152714

Shao, A., & Owens, D. M. (2023). The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy. Oncotarget, 14(1), 96–103. https://doi.org/10.18632/oncotarget.28354

Dioun, S., Chen, L., Hillyer, G., Tatonetti, N. P., May, B. L., Melamed, A., & Wright, J. D. (2022). Association between neighborhood socioeconomic status, built environment and SARS‐CoV‐2 infection among cancer patients treated at a Tertiary Cancer Center in New York City. Cancer Reports, 6(2). Portico. https://doi.org/10.1002/cnr2.1714

Matsuo, K., Duval, C. J., Youssefzadeh, A. C., Mandelbaum, R. S., Ouzounian, J. G., & Wright, J. D. (2022). Prevalence of anxiety and depressive disorders in pregnant women with malignancy. International Journal of Gynecology & Obstetrics, 160(2), 635–640. Portico. https://doi.org/10.1002/ijgo.14335

Liu, D., Liang, C., Huang, B., Zhuang, X., Cui, W., Yang, L., Yang, Y., Zhang, Y., Fu, X., Zhang, X., Du, L., Gu, W., Wang, X., Yin, C., Chai, R., & Chu, B. (2023). Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth. Advanced Science, 10(6). Portico. https://doi.org/10.1002/advs.202204006

Mace, E. M. (2023). Human natural killer cells: Form, function, and development. Journal of Allergy and Clinical Immunology, 151(2), 371–385. https://doi.org/10.1016/j.jaci.2022.09.022

Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., Novick, K. L. M., Sedhom, R., Seigel, C., Stimmel, J., & Bruera, E. (2023). Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology, 41(4), 914–930. https://doi.org/10.1200/jco.22.02198

Rocha, B. G. S., Picoli, C. C., Gonçalves, B. O. P., Silva, W. N., Costa, A. C., Moraes, M. M., Costa, P. A. C., Santos, G. S. P., Almeida, M. R., Silva, L. M., Singh, Y., Falchetti, M., Guardia, G. D. A., Guimarães, P. P. G., Russo, R. C., Resende, R. R., Pinto, M. C. X., Amorim, J. H., Azevedo, V. A. C., … Birbrair, A. (2022). Tissue-resident glial cells associate with tumoral vasculature and promote cancer progression. Angiogenesis, 26(1), 129–166. https://doi.org/10.1007/s10456-022-09858-1

Llanos, A. A. M., Ashrafi, A., Ghosh, N., Tsui, J., Lin, Y., Fong, A. J., Ganesan, S., & Heckman, C. J. (2023). Evaluation of Inequities in Cancer Treatment Delay or Discontinuation Following SARS-CoV-2 Infection. JAMA Network Open, 6(1), e2251165. https://doi.org/10.1001/jamanetworkopen.2022.51165

Shankar, L. K., Huang, E., Litiere, S., Hoekstra, O. S., Schwartz, L., Collette, S., Boellaard, R., Bogaerts, J., Seymour, L., & deVries, E. G. E. (2022). Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response. Clinical Cancer Research, 29(1), 143–153. https://doi.org/10.1158/1078-0432.ccr-21-3143

Wang, Y., Fan, J. L., Melms, J. C., Amin, A. D., Georgis, Y., Barrera, I., Ho, P., Tagore, S., Abril-Rodríguez, G., He, S., Jin, Y., Biermann, J., Hofree, M., Caprio, L., Berhe, S., Khan, S. A., Henick, B. S., Ribas, A., Macosko, E. Z., … Izar, B. (2023). Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature Genetics, 55(1), 19–25. https://doi.org/10.1038/s41588-022-01268-9

Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356

Araujo, D., Greystoke, A., Bates, S., Bayle, A., Calvo, E., Castelo-Branco, L., de Bono, J., Drilon, A., Garralda, E., Ivy, P., Kholmanskikh, O., Melero, I., Pentheroudakis, G., Petrie, J., Plummer, R., Ponce, S., Postel-Vinay, S., Siu, L., Spreafico, A., … Seymour, L. (2023). Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Annals of Oncology, 34(1), 48–60. https://doi.org/10.1016/j.annonc.2022.09.158

Murali, K. P., Yu, G., Merriman, J. D., Vorderstrasse, A., Kelley, A. S., & Brody, A. A. (2021). Multiple Chronic Conditions among Seriously Ill Adults Receiving Palliative Care. Western Journal of Nursing Research, 45(1), 14–24. https://doi.org/10.1177/01939459211041174

Dercle, L., Sun, S., Seban, R.-D., Mekki, A., Sun, R., Tselikas, L., Hans, S., Bernard-Tessier, A., Mihoubi Bouvier, F., Aide, N., Vercellino, L., Rivas, A., Girard, A., Mokrane, F.-Z., Manson, G., Houot, R., Lopci, E., Yeh, R., Ammari, S., & Schwartz, L. H. (2023). Emerging and Evolving Concepts in Cancer Immunotherapy Imaging. Radiology, 306(1), 32–46. https://doi.org/10.1148/radiol.210518

Kehm, R. D., Li, J., Takemoto, E., Yung, J., Qiao, B., Farfel, M. R., & Cone, J. E. (2022). Mortality after the 9/11 terrorist attacks among world trade center health registry enrollees with cancer. Cancer Medicine, 12(2), 1829–1840. Portico. https://doi.org/10.1002/cam4.4992

Li, N., Guo, X., Wu, Y., Yau, V., Song, Q., Su, W., Wang, H., Liang, Q., Liang, M., Ding, X., Lowe, S., Li, Y., Bentley, R., King, B., Zhou, Q., Qu, G., & Sun, C. (2022). Association between household air pollution and all-cause and cause-specific mortality: a systematic review and meta-analysis. Environmental Science and Pollution Research, 30(3), 5312–5346. https://doi.org/10.1007/s11356-022-24222-y

Poghosyan, H., Margaryan, Y., Jeon, S., Edelman, E. J., & Yu, J. B. (2023). Association between social connectedness and stress or anxiety among older cancer survivors during the 2020–2021 winter surge of the COVID-19 pandemic. Journal of Geriatric Oncology, 14(1), 101390. https://doi.org/10.1016/j.jgo.2022.10.005

Irace, A. L., Sharma, R. K., Smith, T. L., Stewart, M. G., & Gudis, D. A. (2022). Impact of Medicaid Expansion on Rhinologic Cancer Presentation, Treatment, and Outcomes. The Laryngoscope, 133(1), 43–50. Portico. https://doi.org/10.1002/lary.30049

Bukhari, S., Henick, B. S., Winchester, R. J., Lerrer, S., Adam, K., Gartshteyn, Y., Maniar, R., Lin, Z., Khodadadi-Jamayran, A., Tsirigos, A., Salvatore, M. M., Lagos, G. G., Reiner, S. L., Dallos, M. C., Mathew, M., Rizvi, N. A., & Mor, A. (2023). Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. Cell Reports Medicine, 4(1), 100868. https://doi.org/10.1016/j.xcrm.2022.100868

Lopci, E., Aide, N., Dimitrakopoulou-Strauss, A., Dercle, L., Iravani, A., Seban, R. D., Sachpekidis, C., Humbert, O., Gheysens, O., Glaudemans, A. W. J. M., Weber, W. A., Van den Abbeele, A. D., Wahl, R. L., Scott, A. M., Pandit-Taskar, N., & Hicks, R. J. (2022). Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer Imaging, 22(1). https://doi.org/10.1186/s40644-022-00512-z

Andrillon, A., Chevret, S., Lee, S. M., & Biard, L. (2022). Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression. Statistics in Medicine, 41(29), 5753–5766. Portico. https://doi.org/10.1002/sim.9591

Erwin, G. S., Gürsoy, G., Al-Abri, R., Suriyaprakash, A., Dolzhenko, E., Zhu, K., Hoerner, C. R., White, S. M., Ramirez, L., Vadlakonda, A., Vadlakonda, A., von Kraut, K., Park, J., Brannon, C. M., Sumano, D. A., Kirtikar, R. A., Erwin, A. A., Metzner, T. J., Yuen, R. K. C., … Snyder, M. P. (2022). Recurrent repeat expansions in human cancer genomes. Nature, 613(7942), 96–102. https://doi.org/10.1038/s41586-022-05515-1

Capaccione, K. M., Valiplackal, J. P., Huang, A., Roa, T., Fruauff, A., Liou, C., Kim, E., Khurana, S., Maher, M., Ma, H., Ngyuen, P., Mak, S., Dumeer, S., Lala, S., D’souza, B., Laifer-Narin, S., Desperito, E., Ruzal-Shapiro, C., & Salvatore, M. M. (2022). Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review. Academic Radiology, 29(12), 1869–1884. https://doi.org/10.1016/j.acra.2022.03.007

Cuppen, E., Elemento, O., Rosenquist, R., Nikic, S., IJzerman, M., Zaleski, I. D., Frederix, G., Levin, L.-Å., Mullighan, C. G., Buettner, R., Pugh, T. J., Grimmond, S., Caldas, C., Andre, F., Custers, I., Campo, E., van Snellenberg, H., Schuh, A., Nakagawa, H., … Jobanputra, V. (2022). Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care. JCO Precision Oncology, 6. https://doi.org/10.1200/po.22.00245

Knotts, R. M., Jin, Z., Doyle, J. B., Keating, C., DiMango, E., & Abrams, J. A. (2022). Body mass index and additional risk factors for cancer in adults with cystic fibrosis. Cancer Causes & Control, 33(12), 1445–1451. https://doi.org/10.1007/s10552-022-01635-1

Watabayashi, K. K., Bell-Brown, A., Kreizenbeck, K., Egan, K., Lyman, G. H., Hershman, D. L., Arnold, K. B., Bansal, A., Barlow, W. E., Sullivan, S. D., & Ramsey, S. D. (2022). Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07835-4

Liu, H., Forouhar, F., Lin, A. J., Wang, Q., Polychronidou, V., Soni, R. K., Xia, X., & Stockwell, B. R. (2022). Small-molecule allosteric inhibitors of GPX4. Cell Chemical Biology, 29(12), 1680-1693.e9. https://doi.org/10.1016/j.chembiol.2022.11.003

Hilmi, M., Naoun, N., Boilève, A., Géraud, A., Bayle, A., Pagès, A., Aupomerol, M., Rouanne, M., Madec, F.-X., Pommeret, F., Massard, C., Baldini, C., Scotté, F., & Champiat, S. (2022). Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study. Supportive Care in Cancer, 30(12), 9841–9849. https://doi.org/10.1007/s00520-022-07407-6

Grant-Alfieri, A., Burke, K., Zeinomar, N., Delgado, M.-L., & Terry, M. B. (2022). Cancer Education Interventions in Adolescents: A Systematic Review of Scope and Content. Health Education & Behavior, 49(6), 993–1003. https://doi.org/10.1177/10901981221109142